Three Rothwell Figg attorney authored articles are among JD Supra's Top-Read articles of 2022 as identified by JD Supra's 2023 Readers Choice Awards. Top-read articles are recognized for having the most reads among the articles published on JD Supra in the industry or on the subject.
Among the life sciences related articles, Rothwell Figg authored two of the top five most-read. These include an article by Dan Shores, Vivian Tian, and Sheena Wang, originally published on the firm's RF EMerge blog, titled "mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook," as well as Aydin Harston's article from the firm's Biosimilars Law Bulletin, "How the U.S. Compares to Europe on Biosimilars Approvals and Products in the Pipeline, Updated March 14, 2022."
The "mRNA Patent and Competitive Landscape" article by Dan, Vivian, and Sheena is also listed among the top-read articles related to patents, as well as Dan's article, "The Current mRNA/LNP Patent Litigation Landscape," also originally from the RF EMerge blog.
JD Supra is a daily source of need-to-know intelligence on professional and personal matters. They publish and distribute the valuable content produced daily by leading business experts: updates, alerts, news analysis, blog posts, videos, and written commentary on myriad topics across all industries and fields. Readers include in-house counsel, business leaders, reporters, editors, and anyone else trying to make sense of regulations and related issues that define their profession, marketplace, or industry. Contributors include over 35,000 attorney writers from some of the world's leading law firms.
To learn more, visit JD Supra's 2023 Readers Choice Awards.
